BIOFRONTERA |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.298 EUR | -12.87% |
|
-.--% | -.--% |
| May. 31 | Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 630B | ||||||
| 350B | - | - | - | - | ||
| 328B | ||||||
| 298B | ||||||
| 246B |
